Anti-interleukin-1 agents for pericarditis: a primer for cardiologists
M Imazio, G Lazaros, M Gattorno… - European Heart …, 2022 - academic.oup.com
Abstract Anti-interleukin (IL)-1 agents have been developed for the treatment of
autoinflammatory and rheumatic conditions, where overproduction of IL-1 is an important …
autoinflammatory and rheumatic conditions, where overproduction of IL-1 is an important …
Recent advances in pericarditis
E Bizzi, C Picchi, G Mastrangelo, M Imazio… - European Journal of …, 2022 - Elsevier
Pericardial diseases are an heterogeneous group of entities, ranging from acute pericarditis
to asymptomatic pericardial effusions. New advances in understanding the processes …
to asymptomatic pericardial effusions. New advances in understanding the processes …
Combining nanotechnology with monoclonal antibody drugs for rheumatoid arthritis treatments
XK Chi, XL Xu, BY Chen, J Su, YZ Du - Journal of Nanobiotechnology, 2023 - Springer
Rheumatoid arthritis (RA) is a systemic immune disease characterized by synovial
inflammation. Patients with RA commonly experience significant damage to their hand and …
inflammation. Patients with RA commonly experience significant damage to their hand and …
Pericarditis and post-cardiac injury syndrome as a sequelae of acute myocardial infarction
Abstract Purpose of Review Pericarditis secondary to acute myocardial infarction (AMI) is
known to develop either immediately or after a latent period of few months. Due to varied …
known to develop either immediately or after a latent period of few months. Due to varied …
The preferential use of anakinra in various settings of FMF: a review applied to an updated treatment-related perspective of the disease
E Giat, I Ben-Zvi, M Lidar, A Livneh - International journal of molecular …, 2022 - mdpi.com
Familial Mediterranean fever (FMF), the most frequent monogenic autoinflammatory
disease, is manifested with recurrent and chronic inflammation and amyloid A (AA) …
disease, is manifested with recurrent and chronic inflammation and amyloid A (AA) …
Protective effect of anakinra on audiovestibular function in a murine model of endolymphatic hydrops
N Zhang, N Li, S Wang, W Xu, J Liu, Y Lyu… - Frontiers in Cellular …, 2022 - frontiersin.org
Introduction Ménière's disease (MD), a common disease in the inner ear, is characterized by
an increase in endolymph in the cochlear duct and vestibular labyrinth. The pathophysiology …
an increase in endolymph in the cochlear duct and vestibular labyrinth. The pathophysiology …
[PDF][PDF] Interleukin-1 receptor antagonist: From synthesis to therapeutic applications
The cytokine channel's mechanism for self-regulation involves the application of
antagonistic cytokines that are synthesized to connect to the receptors and release soluble …
antagonistic cytokines that are synthesized to connect to the receptors and release soluble …
Gli antagonisti dell'interleuchina-1: una nuova classe di farmaci per il trattamento della pericardite ricorrente. Una guida pratica per il cardiologo clinico
M Imazio, G Lazaros, M Gattorno, A Abbate… - Giornale Italiano di …, 2021 - air.unimi.it
Abstract Anti-interleukin (IL)-1 agents have been developed for the treatment of
autoinflammatory diseases characterized by overproduction of IL-1. Idiopathic recurrent …
autoinflammatory diseases characterized by overproduction of IL-1. Idiopathic recurrent …